A groundbreaking clinical trial conducted by researchers from RemediumOne and the Clinical Trials Unit of the University of Kelaniya has demonstrated that CeyCinnXTM, a standardized extract of Ceylon Cinnamon (Cinnamomum zeylanicum), significantly lowers blood sugar levels in patients with Type 2 diabetes mellitus (T2DM). This study, conducted in collaboration with Dr. Dimuthu Muthukuda, Consultant Endocrinologist at Sri Jayewardenepura General Hospital, is the largest clinical trial to date on the potential benefits of Ceylon Cinnamon extracts for diabetes management. The findings have been published in the esteemed journal PLoS ONE.

Read more ...